Human medicines European public assessment report (EPAR): Striascan, ioflupane (123i), Radionuclide Imaging,Dementia,Movement Disorders, Date of authorisation: 25/06/2019

2019 ◽  
Author(s):  
Sign in / Sign up

Export Citation Format

Share Document